To expand its AI medical imaging marketplace, CARPL.ai has raised $10 million.

Delhi-based healthtech startup CARPL.ai has raised $10 million (around ₹96 crore) in a Series A funding round led by the International Finance Corporation (IFC), the private-sector investment arm of the World Bank Group. Existing investor Stellaris Venture Partners and other investors also participated in the funding round. The fresh capital will help the company strengthen its AI-powered medical imaging platform, expand into new international markets, and grow its technology, sales, and delivery teams. CARPL.ai operates one of the world's largest AI marketplaces for radiology, connecting hospitals and diagnostic centers with hundreds of artificial intelligence applications from multiple vendors through a single platform. Instead of integrating separate AI tools individually, healthcare providers can access a wide range of diagnostic solutions through one interface, making AI adoption faster, simpler, and more cost-effective.

The company also plans to enhance its technology stack and expand beyond radiology into areas such as pathology and oncology, enabling broader AI-powered diagnostic support. The funding comes at a time when the healthcare industry is increasingly adopting AI to improve diagnostic accuracy, reduce reporting times, and support radiologists facing growing workloads. Although more than 1,000 FDA-cleared radiology AI applications are available globally, many hospitals struggle with deployment and integration. CARPL.ai addresses this challenge by offering a vendor-neutral platform that allows healthcare providers to evaluate, deploy, and monitor AI applications seamlessly within their existing imaging systems. With this investment, the company aims to accelerate global adoption of AI-driven medical imaging and strengthen its position as a leading healthcare AI platform.